Grindr buys PrEP telehealth company for $250m to put HIV prevention in the app

The dating platform is acquiring Freddie to deliver testing, prescriptions and medication directly to users — closing a prevention gap that leaves 1.5 million eligible Americans off PrEP.

Told by Claire Lawson · 5 October 2026

Grindr just bought a telehealth company for $250 million, which sounds like a tech story until you realise what they're actually buying: the ability to put PrEP directly into the hands of millions of gay men who aren't on it yet.

The dating app announced on 30 September that it's acquiring PurposeMed Inc., the parent company of Freddie, a telehealth provider that specialises in PrEP and HIV prevention care. The deal — $190 million in cash, $60 million in Grindr stock, and up to another $70 million tied to performance targets — is expected to close in the final quarter of 2026.

Here's the gap Grindr is trying to close: about 650,000 people in the US are on PrEP today, despite an estimated 2.2 million who could benefit from it. PrEP reduces the risk of HIV by approximately 99%, and eligible patients can access it at little to no out-of-pocket cost. The medication works. The problem is getting people onto it and keeping them on it.

Freddie has already helped more than 55,000 patients across all 50 US states and five Canadian provinces access PrEP since it launched in Canada in 2020. The company estimates its patients' use of PrEP prevents approximately 385 new HIV transmissions each year — more than one a day — saving the Canadian and US healthcare systems between $270 million and $580 million in future treatment costs annually.

Grindr will fold Freddie together with Woodwork, its existing performance-medication service, into a single Grindr Health experience. Users will be able to learn about PrEP, review their insurance coverage, complete an assessment, meet with a clinician via telehealth, arrange testing, receive a prescription when appropriate, have medication delivered, manage refills, get reminders, and communicate with their care team — all without leaving the app.

Participation is voluntary. Grindr users can choose whether to access care through Freddie; Freddie's existing patients can choose whether to use Grindr. But the bet is straightforward: if you can reduce the friction between thinking about PrEP and actually taking it, more people will stay on it. Testing, refills and clinical support in the same app where you're already talking to people removes one more reason to let a prescription lapse.

"For generations of gay men, HIV shaped how we thought about intimacy, relationships, and our own futures. Today, we have the tools to prevent it. New infections should be close to zero, and that is what we are striving to achieve," Grindr CEO George Arison said in the announcement. "The challenge is connecting people to PrEP and helping them stay on it."

Freddie's CEO, Dr. Husein Moloo, said his company was built to make HIV prevention simple and accessible. "Today we estimate Freddie prevents a new HIV transmission across the US and Canada every day. No one reaches the Freddie community like Grindr does. Together we can bring that care to millions more people, inside the app they already use every day."

This is Grindr's first major acquisition since it was founded in 2009. The company says it's committed to connecting 10 million LGBTQ+ people globally to HIV prevention resources directly through the app by 2028. Freddie expects to generate more than $80 million in revenue and more than $10 million in adjusted EBITDA in 2026.

The gap between 650,000 people on PrEP and 2.2 million who could benefit is not an information problem. It's a care problem — appointments, testing, refills, remembering, the small recurring frictions that make prevention harder than it needs to be. Grindr is betting it can remove enough of those frictions to close the gap. Whether it works depends on whether the app people use to meet each other can also become the app they trust to manage their health. That's the experiment.